Skip to Content
MilliporeSigma
All Photos(2)

Documents

690PB-100A

Sigma-Aldrich

Human Mononuclear Cells: HMNC, adult

Synonym(s):

HMNC, HMNC cells

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41106514
NACRES:
NA.81

biological source

human peripheral blood

form

solid

packaging

pkg of 10,000,000 cells (HMNC-PB)

manufacturer/tradename

Cell Applications, Inc

growth mode

Suspension

karyotype

2n = 46

morphology

mononuclear

technique(s)

cell culture | mammalian: suitable

relevant disease(s)

acquired immunodeficiency syndrome/human immunodeficiency virus (AIDS/HIV); infectious diseases; autoimmune diseases

shipped in

dry ice

storage temp.

−196°C

Related Categories

General description

Lot specific orders are not able to be placed through the web. Contact your local sales rep for more details.

The leukocytes can be divided into two groups: mononuclear and granulocytic cells. The mononuclear cells mainly consist of lymphocytes and monocytes. The lymphocyte population consists of T cells (CD4 and CD8 positive ~75%), B cells and NK cells (~25% combined). In contrast to the granulocytes, these cells have rounded nuclei, some with indentations or folds. The mononuclear cells are involved in various ways with the body′s defense mechanisms.

1. These cells are critical components in the immune system to fight bacterial, viral infections, and function as immune surveillance network to kill tumor cells. The mononuclear cells also secrete a great variety of cytokines to regulate immune response as well as inflammation. Moreover, it has been demonstrated that the mononuclear cells may mediate various biological effects on other tissue and organs. For example, the chemokines produced by monocytes can act on adipocytes and muscles. Human Mononuclear Cells (HMNC) are often extracted from from bone marrow (BM) or peripheral blood (PB) using Ficoll-Hypaque density gradient centrifugation, a hydrophilic polysaccharide that separates layers of blood, with mononuclear cells forming a buffy coat under a layer of plasma. Generally, this buffy coat mainly contains lymphocytes and monocytes, other cell types such as cells are detected in Human Mononuclear Cell (HMNC) preparation.
2. Human Mononuclear Cells (HMNC) are widely used in research and clinical applications every day. The HMNCs are important tool for various studies in the fields of immunology (including auto-immune disorders), infectious disease, hematological malignancies, vaccine development, transplant immunology, and high-throughput screening.
3. HIV research uses them because PBMCs include CD4+ cells, which are the cells HIV infects.
4. Moreover, HMNCs have been accepted as a unique material for cancer immunotheurapy using dendritic cells or activated lymphocytes as an alternative or adjuvant to conventional therapies such as surgery, chemotherapy and radiation treatment.
5,6. Endothelial progenitor cells derived from HMNC have been used in neovascularization to improve limb ischemia
7. In cell therapy to repair ischemic and infracted myocardium.
8. Human Mononuclear Cells (HMNC) should provide a useful tool for studying various aspects of pathology and biology of the human mononuclear cells in vitro.

Human Mononuclear Cells (HMNC) are derived from human peripheral blood (HMNC-PB) using Ficoll-Hypaque density gradient centrifugation. They are cryopreserved immediately after isolation.

1. Allison, A.C. et al, Annu. Rev. Immunol. 1:361 (1983); 2. Sales, V.L. et al, Tissue Eng. 13:525 (2007); 3. Juranic, Z. et al, J. Exp. Clin. Cancer Res. 18:317 (1999); 4. Vicenzi E. et al, J. Leukoc. Biol. 68:405 (2000); 5. Steinman, R. M. et al, Int. J. Cancer 94:459 (2001); 6. Schuler, G., Cancer Immunity 3 (Suppl 1):23 (2003); 7. Kalka, C. et al, Proc. Natl. Acad. Sci. USA 97:3422 (2000); 8. Masuda, H. et al, Cardiovasc. Res. 58:390 (2003)

Cell Line Origin

Human Peripheral Blood

Application

immune surveillance and defense, cytokine and chemokine production, immunoregulation, research, clinical applications, vaccine development, transplant immunology, high-throughput screening, HIV research, cancer immunotherapy, infection fighting, study of T, B and NK cells,

Components

HMNC-PB in DMEM containing 45% FBS & 10% DMSO

Preparation Note

  • Immediately after isolation, 10,000,000 HMNC-PB in DMEM containing 45% FBS & 10% DMSO
  • Blood cells do not proliferate in culture

Subculture Routine

Please refer to the HMNC-PB Culture Protocol.

Disclaimer

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 10

1 of 10

Ficoll®-Paque Premium Cytiva 17-5442-02, pack of 6 × 100 mL

GE17-5442-02

Ficoll®-Paque Premium

vibrant-m

BCR636

Human blood (Pb and Cd)

Histopaque®-1077 sterile-filtered, density: 1.077 g/mL

Sigma-Aldrich

10771

Histopaque®-1077

Ficoll®-Paque Premium Cytiva 17-5442-03, pack of 6 × 500 mL

GE17-5442-03

Ficoll®-Paque Premium

Ficoll®-Paque PREMIUM 1.073 Cytiva 17-5446-52, pack of 6 × 100 mL

GE17-5446-52

Ficoll®-Paque PREMIUM 1.073

Ficoll® Paque Plus Cytiva 17-1440-03, pack of 6 × 500 mL

GE17-1440-03

Ficoll® Paque Plus

Ficoll®-Paque PREMIUM 1.084 Cytiva 17-5446-02, pack of 6 × 100 mL

GE17-5446-02

Ficoll®-Paque PREMIUM 1.084

Ficoll® 400 lyophilized powder, Type 400-DL, BioReagent, suitable for cell culture

Sigma-Aldrich

F8016

Ficoll® 400

Ficoll® PM 400 Type 400

Sigma-Aldrich

F4375

Ficoll® PM 400

Nilesh P Gawas et al.
Oncology reports, 41(4), 2289-2298 (2019-03-01)
Oral squamous cell carcinoma (OSCC) is a leading cause of mortality in India owing to the high percentage of tobacco chewers, smokers and alcohol consumption. OSCC is highly heterogeneous in nature; therefore poses a challenge in the treatment of the
Nilesh P Gawas et al.
Oncology reports, 41(4), 2289-2298 (2019-03-01)
Oral squamous cell carcinoma (OSCC) is a leading cause of mortality in India owing to the high percentage of tobacco chewers, smokers and alcohol consumption. OSCC is highly heterogeneous in nature; therefore poses a challenge in the treatment of the

Protocols

Technical information for working with human mononuclear cells – periphery blood including thawing, subculturing and cryopreservation

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service